Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
Holding CYRX?
Track your performance easily
CYRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.32 - $20.11
Previous Close$8.39
Volume164.72K
Average Volume (3M)834.24K
Market Cap
$415.56M
Enterprise Value$392.03M
Total Cash (Recent Filing)$427.14M
Total Debt (Recent Filing)$404.60M
Price to Earnings (P/E)―
Beta2.54
Next Earnings
Nov 07, 2024EPS Estimate
-$0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.67
Shares Outstanding49,412,294
10 Day Avg. Volume424,010
30 Day Avg. Volume834,242
Standard Deviation0.21
R-Squared0.15
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.12
Price to Sales (P/S)1.82
Price to Cash Flow (P/CF)-12.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.74
Enterprise Value/Gross Profit3.95
Enterprise Value/Ebitda-2.85
Forecast
1Y Price Target
$12.83Price Target Upside52.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
CryoPort News
Bulls Say, Bears Say
Bulls Say
Corporate StrategyA new restructuring program and a new repurchase program have been announced.
Financial PerformanceThe quarter was decent: in line revenue, sequentially improving margins and profitability.
Growth PotentialCYRX grew the total cell & gene therapy clinical trials to 675 from 652 at the end of 1Q23.
Bears Say
Demand And RevenueThe top line decreased 5% Q/Q, and 13% Y/Y, primarily due to a further decrease in demand for MVE products and slowed growth of services.
Management CredibilityStock is expected to remain in the penalty box as it will take time for management to rebuild credibility around forecasting after cutting guidance mid-year for the third straight year.
Revenue GuidanceFY24 revenue growth guidance was lowered to -1% at the midpoint from +6% previously.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $5.32 and its highest was $20.11 in the past 12 months.
What is CryoPort Inc’s market cap?
Currently, no data Available
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is Nov 07, 2024 which is in 50 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on Aug 06, 2024. The company reported -$1.62 earnings per share for the quarter, missing the consensus estimate of -$0.397 by -$1.223.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -$0.31.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 49,412,292 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$1.62 in its last earnings report, missing expectations of -$0.397. Following the earnings report the stock price went down -0.257%.
Which hedge fund is a major shareholder of CryoPort Inc?
Among the largest hedge funds holding CryoPort Inc’s share is Blackstone Inc.. It holds CryoPort Inc’s shares valued at 3M.
---
CryoPort Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.83 (52.56% Upside)
$12.83 (52.56% Upside)
Blogger Sentiment
Bearish
CYRX Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 49.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $26.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.05%
12-Months-Change
Fundamentals
Return on Equity
-36.54%
Trailing 12-Months
Asset Growth
-17.30%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
---
CYRX Earnings Call
Q2 2024
0:00 / 0:00
---
CYRX Stock 12 Month Forecast
Average Price Target
$12.83
▲(52.56% Upside)
Technical Analysis
Best Analysts Covering CYRX
1 Year
1 Year Success Rate
2/22 ratings generated profit
1 Year Average Return
-36.52%
reiterated a buy rating last month
Copying David Saxon's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -36.52% per trade.
---